Cargando…
Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review)
Cardiovascular diseases (CVDs), such as atherosclerosis, hypertension, myocardial infarction and diabetic heart disease, are associated with high morbidity and mortality rates worldwide, and may also induce multiple organ failure in their later stages, greatly reducing the long-term survival of the...
Autores principales: | Zhu, Ying, Shui, Xiaorong, Liang, Zheng, Huang, Zufeng, Qi, Yi, He, Yuan, Chen, Can, Luo, Hui, Lei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388831/ https://www.ncbi.nlm.nih.gov/pubmed/32705240 http://dx.doi.org/10.3892/ijmm.2020.4674 |
Ejemplares similares
-
Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
por: Chen, Xiaofeng, et al.
Publicado: (2023) -
Gut microbiota derived metabolites in cardiovascular health and disease
por: Wang, Zeneng, et al.
Publicado: (2018) -
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
por: Brial, Francois, et al.
Publicado: (2018) -
Role of the gut microbiota and their metabolites in hemodialysis patients
por: Chao, Ying Ting, et al.
Publicado: (2023) -
Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation
por: Li, Chenyu, et al.
Publicado: (2022)